(Q37473309)

English

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma (English)

1 reference

Europe PubMed Central

20 August 2017

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Nathan E Hoffmann

1

1 reference

Europe PubMed Central

20 August 2017

Yuri Sheinin

2

1 reference

Europe PubMed Central

20 August 2017

Christine M Lohse

3

1 reference

Europe PubMed Central

20 August 2017

Alexander S Parker

4

1 reference

Europe PubMed Central

20 August 2017

Bradley C Leibovich

5

1 reference

Europe PubMed Central

20 August 2017

Zhong Jiang

6

1 reference

Europe PubMed Central

20 August 2017

Eugene D Kwon

7

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

112

1 reference

Europe PubMed Central

20 August 2017

1471-1479

1 reference

Europe PubMed Central

20 August 2017

7

1 reference

Europe PubMed Central

20 August 2017

Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

What do we mean by validating a prognostic model?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

Assessing the generalizability of prognostic information

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

23 August 2017

External validation is necessary in prediction research: a clinical example

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

14 September 2017

The Heidelberg classification of renal cell tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

26 June 2018

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

2 September 2018

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

2 September 2018

Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

2 September 2018

Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

2 September 2018

An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792740

2 September 2018

Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/18260086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18260086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma with non-islet cell tumor hypoglycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18260086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other

1 reference

https://pubmed.ncbi.nlm.nih.gov/18260086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18260086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18260086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23296

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23296

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37473309&oldid=2087357581"